Erratum: Bimatoprost 0.01% vs bimatoprost 0.03%: a 12-month prospective trial of clinical and in vivo confocal microscopy in glaucoma patients

被引：0
|
作者：
M Figus
M Nardi
P Piaggi
M Sartini
G Guidi
L Martini
S Lazzeri
机构：
来源：
Eye | 2014年 / 28卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Correction to: Eye (2014) 28, 422–429; doi:10.1038/eye.2013.304; published online 17 January 2014 Since the publication of the above article, it has been noted that the colour of the lines in Figure 1 were the wrong way round. The correct figure appears below. The authors apologise for this error.
引用
收藏
页码：506 / 506
相关论文
共 50 条
  • [31] Six-month randomized clinical trial comparing intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma
    Fellenbaum, PS
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2003, 136 (02) : 392 - 392
  • [32] A six-month randomized clinical trial comparing the intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma
    Noecker, RS
    Dirks, MS
    Choplin, NT
    Bernstein, P
    Batoosingh, AL
    Whitcup, SM
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2003, 135 (01) : 55 - 63
  • [33] Reporting of 6-month vs 12-month data in a clinical trial of celecoxib
    Hrachovec, JB
    Mora, M
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (19): : 2398 - 2398
  • [34] Bimatoprost 0.01% in treatment-naive patients with open-angle glaucoma or ocular hypertension: an observational study in the Korean clinical setting
    Park, Ki Ho
    Simonyi, Susan
    Kim, Chan Yun
    Sohn, Yong Ho
    Kook, Michael Scott
    BMC OPHTHALMOLOGY, 2014, 14
  • [35] A six-month randomized clinical trial comparing the IOP-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma - Author reply
    Noecker, RS
    Dirks, MS
    Choplin, NT
    Bernstein, P
    Batoosingh, AL
    Whitcup, SM
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2003, 135 (06) : 922 - 923
  • [36] Bimatoprost Sustained-Release Implants for Glaucoma Therapy: 6-Month Results From a Phase I/II Clinical Trial
    Lewis, Richard A.
    Christie, William C.
    Day, Douglas G.
    Craven, E. Randy
    Walters, Thomas
    Bejanian, Marina
    Lee, Susan S.
    Goodkin, Margot L.
    Zhang, Jane
    Whitcup, Scott M.
    Robinson, Michael R.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2017, 175 : 137 - 147
  • [37] Bimatoprost 0.01% in treatment-naïve patients with open-angle glaucoma or ocular hypertension: an observational study in the Korean clinical setting
    Ki Ho Park
    Susan Simonyi
    Chan Yun Kim
    Yong Ho Sohn
    Michael Scott Kook
    BMC Ophthalmology, 14
  • [38] Reporting of 6-month vs 12-month data in a clinical trial of celecoxib - Reply
    Silverstein, F
    Simon, L
    Faich, G
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (19): : 2399 - 2400
  • [39] CLINICAL AND ECONOMIC OUTCOMES OF LATANOPROST BIMATOPROST OR TRAVOPROST THERAPY IN GLAUCOMA PATIENTS: A THREE-MONTH RETRO-SPECTIVE STUDY
    G.F.Schwartz
    C.P.Schaefer
    Y.C.Yeh
    J.Nordin
    E.Mozaffari
    国际眼科杂志, 2003, (01) : 87 - 88
  • [40] A 3-month randomized controlled trial of bimatoprost (LUMIGAN) versus combined timolol and dorzolamide (Cosopt) in patients with glaucoma or ocular hypertension
    Coleman, AL
    Lerner, F
    Bernstein, P
    Whitcup, SM
    OPHTHALMOLOGY, 2003, 110 (12) : 2362 - 2368
12345